In Europe, Tinea unguium has an incidence rate between 0 and 2.6% (average 0.3%) in general population. The symptoms of tinea of the nails are generally well tolerated by patients, causing a delay in ...

The global analytical report has been made by using significant data research methodologies such as primary and secondary research. The research report mainly introduced the global Onychomycosis ...

The diagnosis and treatment of tinea of the nail poses a challenge as the symptoms of tinea are well tolerated resulting in delayed consultation and due to a incidence rate of 0.3% (average). An ...

New York, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Onychomycosis (Tinea Unguium) Global Clinical Trials Review, H2 ...

Dermatologists yesterday urged people who have attempted in vain to treat a common fungal infection of the nails known as onychomycosis or tinea unguium to immediately seek medical advice, as the ...

Vanda Pharmaceuticals Inc. (Vanda), a leading global biopharmaceutical company, announced that the US Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application to ...

MarketsandResearch.biz has introduced a new report entitled Global Onychomycosis (Tinea Unguium) Drug Market 2021 by Company, Regions, Type and Application, Forecast to 2026 which is based on ...

Doctors have observed, through a research carried out during the past 9 years, an increase in the number of children affected by tinea of the nails, as well as an underdiagnosis of this affection by ...